K. Wyatt Engwall, Director at THERAGENICS CORP (TGX), bought 21,000 shares at $3.32 ($70K) on 2008-08-28, disclosed to the SEC on 2008-08-28.
Open-market purchase of $70k TGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.36 | 11,000 | $37K | 52.7% |
| 2 | $3.32 | 10,000 | $33K | 47.3% |
| Total | $3.34 avg | 21,000 | $70K | 100% |
| Filing → |
| TGX | BUY | 2010-02-22 | $68K | — | Filing → |
| TGX | BUY | 2008-11-07 | $30K | — | Filing → |